Anxiety and Related Sleep Disorders - BRICS

  • BRICS
  • Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$1.11bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.36%, resulting in a market volume of US$1.13bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
  • In relation to total population figures, per person revenues of US$8.54 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Anxiety and Related Sleep Disorders market in BRICS is experiencing significant growth due to a variety of factors. Customer preferences for alternative treatments and a growing awareness of mental health issues are driving the demand for products in this market. Additionally, local special circumstances and underlying macroeconomic factors in each country are contributing to the development of the market.Customer preferences in the BRICS countries are shifting towards alternative treatments for anxiety and sleep disorders. Traditional methods of treatment, such as pharmaceuticals, are being supplemented or replaced by natural remedies, therapy, and lifestyle changes. This shift is driven by a desire for holistic approaches to health and a growing awareness of the potential side effects of pharmaceutical medications. As a result, there is a growing demand for natural and alternative products in the market.Trends in the market vary across the BRICS countries. In Brazil, there is a growing interest in natural remedies and therapies for anxiety and sleep disorders. The country has a rich tradition of herbal medicine, and consumers are increasingly turning to these traditional remedies. In Russia, there is a growing demand for pharmaceutical products, as the country has a well-established pharmaceutical industry. India, on the other hand, has a strong tradition of yoga and meditation, and consumers are increasingly seeking out these practices to manage their anxiety and sleep disorders. In China, there is a growing interest in traditional Chinese medicine, which includes herbal remedies and acupuncture, as well as Western pharmaceuticals.Local special circumstances also play a role in the development of the Anxiety and Related Sleep Disorders market in BRICS. For example, in Brazil, the high prevalence of anxiety disorders and sleep disorders among the population is driving the demand for products in this market. In Russia, the government has implemented policies to promote mental health awareness and treatment, which has led to increased demand for products in this market. In India, the growing middle class and increasing urbanization are contributing to the development of the market, as more people are seeking treatment for anxiety and sleep disorders. In China, the aging population and changing lifestyles are driving the demand for products in this market.Underlying macroeconomic factors also contribute to the development of the Anxiety and Related Sleep Disorders market in BRICS. Economic growth and rising disposable incomes in these countries have led to an increase in healthcare spending, including spending on mental health. Additionally, increasing urbanization and changing lifestyles have led to higher levels of stress and anxiety, driving the demand for products in this market. Furthermore, government initiatives to improve mental health awareness and treatment have also contributed to the growth of the market.Overall, the Anxiety and Related Sleep Disorders market in BRICS is developing due to customer preferences for alternative treatments, local special circumstances, and underlying macroeconomic factors. As awareness of mental health issues continues to grow and disposable incomes rise, the market is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)